Teenagers and young adults with cancer need better access to clinical trialsBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f1959 (Published 25 March 2013) Cite this as: BMJ 2013;346:f1959
- Zosia Kmietowicz
The number of teenagers and young adults dying from cancer in the United Kingdom has halved since the 1970s, show figures in a new report. But clinicians have said that too few people in this age group are being enrolled in clinical trials and that the development of new treatments has been poor as a result.
The report from Cancer Research UK said that each year cancer is diagnosed in around 2200 young people aged between 15 and 24 years and that around 310 die from it, down from about 580 deaths a year in the mid-1970s.1
The death rate from cancer in teenagers and young adults fell from 74.5 per million …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial